Answer
During Duodopa treatment, carbidopa does not cross the blood-brain barrier but inhibits levodopa decarboxylation outside the brain, leaving more levodopa available for transport into the brain and conversion to dopamine.
Sources for this answer
- Duodopa intestinal gelAbbVie Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 22Document updated
Sources checked